positive
Rubicon Research Ltd IPO Opens on October 9, 2025
Rubicon Research Ltd, a Indian pharmaceutical company, is launching a ₹1,377.5 crore IPO from Oct 9-13, 2025. The issue is a combination of a ₹500 crore fresh issue and ₹877.5 crore offer for sale. Retail investors can subscribe to up to 10% of the net offer. Listing is expected on BSE and NSE around Oct 16, 2025.
Companies:
- Rubicon Research Ltd
Tags:
- IPO
- Rubicon Research
Rubicon• By Harsh Ranjan
Explore:Mutual Fund AI Screening
positive
Rubicon Research Ltd IPO Opens on October 9, 2025
Rubicon Research Ltd, a Indian pharmaceutical company, is launching a ₹1,377.5 crore IPO from Oct 9-13, 2025. The issue is a combination of a ₹500 crore fresh issue and ₹877.5 crore offer for sale. Retail investors can subscribe to up to 10% of the net offer. Listing is expected on BSE and NSE around Oct 16, 2025.
Companies:
- Rubicon Research Ltd
Tags:
- IPO
- Rubicon Research
Rubicon• By Harsh Ranjan
Explore:Mutual Fund AI Screening
1 min read
57 words
Rubicon Research IPO opens Oct 9 for ₹1,377.5 Cr, retail portion 10%.
Rubicon Research Ltd, a Indian pharmaceutical company, is launching a ₹1,377.5 crore IPO from Oct 9-13, 2025. The issue is a combination of a ₹500 crore fresh issue and ₹877.5 crore offer for sale. Retail investors can subscribe to up to 10% of the net offer. Listing is expected on BSE and NSE around Oct 16, 2025.
Rubicon Research Ltd, a Indian pharmaceutical company, is launching a ₹1,377.5 crore IPO from Oct 9-13, 2025. The issue is a combination of a ₹500 crore fresh issue and ₹877.5 crore offer for sale. Retail investors can subscribe to up to 10% of the net offer. Listing is expected on BSE and NSE around Oct 16, 2025.
Companies:
- Rubicon Research Ltd
Tags:
- IPO
- Rubicon Research
- IPO
- Rubicon Research
- Pharmaceuticals
- Stock Market